CV psychedelik - Publikace

VEJMOLA, Č., TYLŠ, F., PIORECKÁ, V., KOUDELKA, V., KADEŘÁBEK, L., NOVÁK, T., PÁLENÍČEK, T. Psilocin, LSD, mescaline, and DOB all induce broadband desynchronization of EEG and disconnection in rats with robust translational validity. Translational Psychiatry. 2021, 11(1), "Article Number: 506". ISSN 2158-3188. DOI: 10.1038/s41398-021-01603-4. IF 6.222.

TYLŠ, F., PÁLENÍČEK, T., HORÁČEK, J. Psilocybin - Summary of knowledge and new perspectives. European Neuropsychopharmacology. 2014, 24(3), 342-356. ISSN 0924-977X. DOI: 10.1016/j.euroneuro.2013.12.006. IF 4.369.

HLOŽEK, T., UTTL, L., KADEŘÁBEK, L., BALÍKOVÁ, M., LHOTKOVÁ, E., HORSLEY, RR., NOVÁKOVÁ, P., ŠÍCHOVÁ, K., ŠTEFKOVÁ, K., TYLŠ, F., KUCHAŘ, M., PÁLENÍČEK, T. Pharmacokinetic and behavioural profile of THC, CBD, and THC plus CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC. European Neuropsychopharmacology. 2017, 27(12), 1223-1237. ISSN 0924-977X. DOI: 10.1016/j.euroneuro.2017.10.037. IF 4.129.

ŠULÁKOVÁ, A., NYKODEMOVA, J., PALIVEC, P., JUROK, P., RIMPELOVA, S., LEONHARDT, T., ŠÍCHOVÁ, K., PÁLENÍČEK, T., KUCHAŘ, M. 25CN-NBOMe Metabolites in Rat Urine, Human Liver Microsomes and C. elegans-Structure Determination and Synthesis of the Most Abundant Metabolites. Metabolites. 2021, 11(4), "Article Number: 212". ISSN 2218-1989. DOI: 10.3390/metabo11040212. IF 4.932.

DUDYSOVÁ, D., JANKŮ, K., ŠMOTEK, M., SAIFUTDINOVA, E., KOPŘIVOVÁ, J., BUŠKOVÁ, J., MANDER, BA., BRUNOVSKÝ, M., ZACH, P., KORČÁK, J., ANDRASHKO, V., VIKTORINOVÁ, M., TYLŠ, F., BRAVERMANOVÁ, A., FROESE, T., PÁLENÍČEK, T., HORÁČEK, J. The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action. Frontiers in Pharmacology. 2020, 11("Article Number: 602590"), 1-9. ISSN 1663-9812. DOI: 10.3389/fphar.2020.602590. IF 5.810.

JIŘÍČEK, S., KOUDELKA, V., LACIK, J., VEJMOLA, Č., KURATKO, D., WOJCI, DK., RAIDA, Z., HLINKA, J., PÁLENÍČEK, T. Electrical Source Imaging in Freely Moving Rats: Evaluation of a 12-Electrode Cortical Electroencephalography System. Frontiers in Neuroinformatics. 2021, 14("Article number 589228"), 1-22. ISSN 1662-5196. DOI: 10.3389/fninf.2020.589228. IF 4.081.

ZAYTSEVA, Y., HORÁČEK, J., HLINKA, J., FAJNEROVÁ, I., ANDROVIČOVÁ, R., TINTĚRA, J., SALVI, V., BALÍKOVÁ, M., HLOŽEK, T., ŠPANIEL, F., PÁLENÍČEK, T. Cannabis-induced altered states of consciousness are associated with specific dynamic brain connectivity states. Journal of Psychopharmacology. 2019, 33(7), 811-821. ISSN 0269-8811. DOI: 10.1177/0269881119849814. IF 3.121.

FROESE, T., LEENEN, I., PÁLENÍČEK, T. A role for enhanced functions of sleep in psychedelic therapy?. Adaptive Behavior. 2018, 26(3), 129-135. ISSN 1059-7123. DOI: 10.1177/1059712318762735. IF 1.362.

BRAVERMANOVÁ, A., VIKTORINOVÁ, M., TYLŠ, F., NOVÁK, T., ANDROVIČOVÁ, R., KORČÁK, J., HORÁČEK, J., BALÍKOVÁ, M., GRIŠKOVA-BULANOVA, I., DANIELOVÁ, D., VLČEK, P., MOHR, P., BRUNOVSKÝ, M., KOUDELKA, V., PÁLENÍČEK, T. Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers. Psychopharmacology. 2018, 235(2), 491-503. ISSN 0033-3158. DOI: 10.1007/s00213-017-4807-2. IF 3.424.

ŠTEFKOVÁ, K., ŽIDKOVÁ, M., HORSLEY, RR., PINTEROVÁ, N., ŠÍCHOVÁ, K., UTTL, L., BALÍKOVÁ, M., DANDA, H., KUCHAŘ, M., PÁLENÍČEK, T. Pharmacokinetic, ambulatory, and hyperthermic effects of 3,4-methylenedioxy-n-methylcathinone (Methylone) in rats. Frontiers in Psychiatry. 2017, 8("Article Number: 232"), 1-11. ISSN 1664-0640. DOI: 10.3389/fpsyt.2017.00232. IF 2.857.

HORSLEY, RR., LHOTKOVÁ, E., HÁJKOVÁ, K., FERIANCIKOVA, B., HIML, M., KUCHAŘ, M., PÁLENÍČEK, T. Behavioural, pharmacokinetic, metabolic, and hyperthermic profile of 3,4-Methylenedioxypyrovalerone (MDPV) in the wistar rat. Frontiers in Psychiatry. 2018, 9(Article Number: 144), 1-13. ISSN 1664-0640. DOI: 10.3389/fpsyt.2018.00144. IF 3.161.

HORSLEY, RR., PÁLENÍČEK, T., KOLIN, J., VALEŠ, K. Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats. Behavioural Pharmacology. 2018, 29(6), 530-536. ISSN 0955-8810. DOI: 10.1097/FBP.0000000000000394. IF 1.788.

FUJÁKOVÁ, M., PÁLENÍČEK, T., BRUNOVSKÝ, M., GORMAN, I., TYLŠ, F., KUBEŠOVÁ, A., ŘÍPOVÁ, D., KRAJČA, V., HORÁČEK, J. The effect of ((-)-2-oxa-4-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY379268), an mGlu2/3 receptor agonist, on EEG power spectra and coherence in ketamine model of psychosis. Pharmacology Biochemistry and Behavior. 2014, 122(July), 212-221. ISSN 0091-3057. DOI: 10.1016/j.pbb.2014.03.001. IF 2.781.

ANDROVIČOVÁ, R., HORÁČEK, J., TINTĚRA, J., HLINKA, J., RYDLO, J., JEZOVA, D., BALÍKOVÁ, M., HLOŽEK, T., MIKŠÁTKOVÁ, P., KUCHAŘ, M., ROMAN, M., TOMICEK, P., TYLŠ, F., VIKTORINOVÁ, M., PÁLENÍČEK, T. Individual prolactin reactivity modulates response of nucleus accumbens to erotic stimuli during acute cannabis intoxication: an fMRI pilot study. Psychopharmacology. 2017, 234(13), 1933-1943. ISSN 0033-3158. DOI: 10.1007/s00213-017-4601-1. IF 3.222.

HORÁČEK, J., PÁLENÍČEK, T., MÁLEK, J., SCIGEL, V., KURZOVÁ, A., HESS, L. The influence of clonidine on oral ketamine-midazolam premedication in intellectually disabled patients indicated for dental procedures: Double-blind comparison of two sedation regimes. Neuroendocrinology Letters. 2012, 33(4), 380-384. ISSN 0172-780X. IF 0.932.

HORÁČEK, J., BRUNOVSKÝ, M., NOVÁK, T., KOHÚTOVÁ, B., PÁLENÍČEK, T., BUBENÍKOVÁ-VALEŠOVÁ, V., ŠPANIEL, F., KOPŘIVOVÁ, J., MOHR, P., BALÍKOVÁ, M., HÖSCHL, C. Subanesthetic dose of ketamine decreases prefrontal theta cordance in healthy volunteers: implications for antidepressant effect. Psychological Medicine. 2010, 40(9), 1443-1451. ISSN 0033-2917. DOI: 10.1017/S0033291709991619. IF 5.200.

PÁLENÍČEK, T., HLIŇÁK, Z., BUBENÍKOVÁ-VALEŠOVÁ, V., NOVÁK, T., HORÁČEK, J. Sex differences in the effects of N,N-diethyllysergamide (LSD) on behavioural activity and prepulse inhibition. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2010, 34(4), 588-596. ISSN 0278-5846. DOI: 10.1016/j.pnpbp.2010.02.008. IF 2.877.

PÁLENÍČEK, T., BALÍKOVÁ, M., BUBENÍKOVÁ-VALEŠOVÁ, V., HORÁČEK, J. Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose. Psychopharmacology. 2008, 196(1), 51-62. ISSN 0033-3158. DOI: 10.1007/s00213-007-0926-5. IF 3.676.

PÁLENÍČEK, T., FUJÁKOVÁ, M., BRUNOVSKÝ, M., BALÍKOVÁ, M., HORÁČEK, J., GORMAN, I., TYLŠ, F., TIŠLEROVÁ, B., ŠÓŠ, P., BUBENÍKOVÁ-VALEŠOVÁ, V., HÖSCHL, C., KRAJČA, V. Electroencephalographic spectral and coherence analysis of ketamine in rats: correlation with behavioral effects and pharmacokinetics. Neuropsychobiology. 2011, 63(4), 202-218. ISSN 0302-282X. DOI: 10.1159/000321803. IF 2.675.

UTTL, L., HLOŽEK, T., MAREŠ, P., PÁLENÍČEK, T., KUBOVÁ, H. Anticonvulsive effects and pharmacokinetic profile of cannabidiol (Cbd) in the pentylenetetrazol (ptz) or n‐methyl‐d‐aspartate (nmda) models of seizures in infantile rats. International Journal of Molecular Sciences. 2022, 23(1), "Article Number: 94". ISSN 1661-6596. DOI: 10.3390/ijms23010094. IF 6.208.